Long-Acting Calcium Antagonists in Patients with Coronary Artery Disease: A Meta-Analysis
To access this article, please choose from the options below
Funding: None.
Conflicts of Interest: Sripal Bangalore: no disclosures; Sanobar Parkar: no disclosures; Franz H Messerli: Speakers' Bureau—Abbott, GlaxoSmithKline, Novartis, Pfizer, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Forest, Sankyo, Sanofi. Research/Grants—GlaxoSmithKline, Pfizer, Novartis, CardioVascular Therapeutics.
Authorship: All authors had access to the data and had a role in writing the manuscript.
PII: S0002-9343(08)01104-2
doi:10.1016/j.amjmed.2008.09.043
© 2009 Elsevier Inc. All rights reserved.

